Evaluates surgery timing with cenobamate in drug resistant focal epilepsy, indicating treatment impact.
To evaluate whether surgery was obtained within 12 months for patients who received cenobamate as a treatment during the presurgical evaluation and those who did not, comparing across years before and after cenobamate approval at a single center.
No takes yet. Share an insight, caveat, or question.
Pellinen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: